These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 35220244

  • 1. Should 68Ga-PSMA PET/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer?
    Pepe P, Pennisi M.
    Anticancer Res; 2022 Mar; 42(3):1495-1498. PubMed ID: 35220244
    [Abstract] [Full Text] [Related]

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Mar; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 3. How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
    Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F.
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [Abstract] [Full Text] [Related]

  • 4. Primary lymph-node staging with 68Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens.
    Corona-Montes VE, González-Cuenca E, Fernández-Noyola G, Olarte-Casas MA, Bobadilla-Salazar D, Medrano-Urtecho HM, Asimakopoulos AD.
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD.
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [Abstract] [Full Text] [Related]

  • 6. The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.
    Gultekin MH, Demirci E, Turegun FA, Kabasakal L, Sahin OE, Ocak M, Onal B, Erozenci A.
    Urol J; 2020 Dec 09; 18(1):58-65. PubMed ID: 33349912
    [Abstract] [Full Text] [Related]

  • 7. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
    Zang S, Shao G, Cui C, Li TN, Huang Y, Yao X, Fan Q, Chen Z, Du J, Jia R, Sun H, Hua Z, Tang J, Wang F.
    Oncotarget; 2017 Feb 14; 8(7):12247-12258. PubMed ID: 28103574
    [Abstract] [Full Text] [Related]

  • 8. Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy.
    Nikitas J, Gafita A, Benz MR, Djaïleb L, Farolfi A, Hotta M, Sonni I, Alano R, Rettig M, Shen J, Armstrong W, Grogan T, Liu S, Czernin J, Calais J.
    Sci Rep; 2024 Oct 18; 14(1):24411. PubMed ID: 39420060
    [Abstract] [Full Text] [Related]

  • 9. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
    Zhao R, Li Y, Nie L, Qin K, Zhang H, Shi H.
    Medicine (Baltimore); 2021 Apr 16; 100(15):e25417. PubMed ID: 33847640
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients.
    Uslu-Beşli L, Sağer S, Akgün E, Asa S, Şahin OE, Demirdağ Ç, Güner E, Khosroshahi BR, Karayel E, Pehlivanoğlu H, Aygün A, Uslu İ, Talat Z, Sönmezoğlu K.
    Turk J Med Sci; 2019 Feb 11; 49(1):301-310. PubMed ID: 30761859
    [Abstract] [Full Text] [Related]

  • 11. A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.
    Lawal IO, Mokoala KMG, Mahapane J, Kleyhans J, Meckel M, Vorster M, Ebenhan T, Rösch F, Sathekge MM.
    Eur J Nucl Med Mol Imaging; 2021 Jan 11; 48(1):134-142. PubMed ID: 32424485
    [Abstract] [Full Text] [Related]

  • 12. Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.
    Zhao G, Ji B.
    AJR Am J Roentgenol; 2022 Sep 11; 219(3):386-395. PubMed ID: 35441529
    [Abstract] [Full Text] [Related]

  • 13. Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer.
    Algın E, Okudan B, Açıkgöz Y, Sayan H, Bal Ö, Seven B.
    Curr Med Imaging; 2024 Sep 11; 20():e15734056276494. PubMed ID: 38284703
    [Abstract] [Full Text] [Related]

  • 14. Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer.
    Barbosa ÁRG, Amaral BS, Lourenço DB, Bianco B, Gushiken FA, Apezzato M, Silva JF, Cunha MLD, Filippi RZ, Baroni RH, Lemos GC, Carneiro A.
    Einstein (Sao Paulo); 2022 Sep 11; 20():eAO6599. PubMed ID: 35584444
    [Abstract] [Full Text] [Related]

  • 15. 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
    Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KMG, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM.
    Clin Genitourin Cancer; 2018 Oct 11; 16(5):392-401. PubMed ID: 30120038
    [Abstract] [Full Text] [Related]

  • 16. The diagnostic accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP bone scintigraphy for identifying bone metastases in persons with prostate cancer: A systematic review.
    Daniels H, Gilbert R, Bonin L.
    J Med Imaging Radiat Sci; 2023 Sep 11; 54(3):545-555. PubMed ID: 37211439
    [Abstract] [Full Text] [Related]

  • 17. 68 Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer.
    Hruby G, Eade T, Emmett L, Ho B, Hsiao E, Schembri G, Guo L, Kwong C, Hunter J, Byrne K, Kneebone A.
    Asia Pac J Clin Oncol; 2018 Aug 11; 14(4):343-346. PubMed ID: 29663686
    [Abstract] [Full Text] [Related]

  • 18. 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer.
    Kopp D, Kopp J, Bernhardt E, Manka L, Beck A, Gerullis H, Karakiewicz PI, Salomon G, Wiggermann P, Hammerer P, Schiffmann J.
    Urol Int; 2022 Aug 11; 106(1):56-62. PubMed ID: 33965965
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer.
    Acar E, Bekiş R, Polack B.
    Curr Med Imaging Rev; 2019 Aug 11; 15(6):589-594. PubMed ID: 32008568
    [Abstract] [Full Text] [Related]

  • 20. [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.
    Hirmas N, Al-Ibraheem A, Herrmann K, Alsharif A, Muhsin H, Khader J, Al-Daghmin A, Salah S.
    Mol Imaging Biol; 2019 Jun 11; 21(3):574-581. PubMed ID: 30215174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.